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The Médicins sans Frontières 
(MSF) Treatment Centre, 
Monrovia 
The MSF Ebola Treatment Centre in Liberia, 
ELWA 3, opened in August 2014 and was the 
largest treatment centre ever built. Its 240 beds far exceeded 
the 20-bed centres in previous outbreaks. ELWA 3 was a field 
hospital; wards were tents, and there were no actual beds, but 
mattresses on the floor. Hygiene facilities consisted of latrines 
and stand-pipes for water and chlorine. The 15-person tents 
opened into a large outside courtyard within the high-risk area, 
where the patients who could mobilise would sit, pass the time of 
day, support each other, and help the less able patients.
Ebola virus disease (EVD) affects people who are in close contact 
with one another, so affects families. We frequently had three 
generations of the same family admitted, including children and 
babies. Families arrived together, but often did not go home together. 
We often discovered that family groups were related when people 
died and there was widespread grieving. Mortality at ELWA was 
60%, as for the average mortality this outbreak.[1]
The number of new cases in Monrovia peaked in September 2014, 
when the treatment centre was overwhelmed with patients, and was 
unable to admit everyone needing care.[2] People were dying outside 
the gates. When I arrived in October, a government-run treatment 
centre had opened, relieving the pressure on ELWA. People were no 
longer turned away at the gates. In November, the number of new 
cases was falling. However, the collective memory of these times 
convinced many staff that the respite would only be temporary, and 
that the tough times would imminently return.
At the peak of the outbreak there were around 70 international 
MSF staff and 700 Liberian staff. As doctors, we were a minority. Four 
of us were involved with patient care, each looking after 60 patients. 
We worked with Liberian physician assistants – there are few doctors 
in Liberia.
As international staff, we were there for the short term. The 
national staff were there for the long term, most remaining until the 
centre closed early in 2015. Many had not revealed to their families 
where they were working, fearing that they would be stigmatised and 
ostracised. Playing their part in eradicating Ebola was the reason 
many joined; economic isssues were also important. Many jobs 
disappeared during the outbreak, schools were closed, and salaries 
were no longer paid.
Medical care of Ebola patients
ELWA was a centre for both diagnosis and treatment. A Centers for 
Disease Control laboratory a few minutes’ walk away performed 
Ebola polymerase chain reaction tests, with a turn around time of a 
few hours. No haematology or biochemistry testing was available.
For patients with confirmed EVD, the clinical care was basic. [3] 
Oral rehydration fluid was the mainstay of fluid management. 
Intravenous fluids had been discontinued when ELWA was 
overwhelmed with patients, as the risk of staff being infected was 
considered too high. We had no means of assessing fluid balance – 
input or output. Many patients were too weak or confused to drink 
unaided, and would be helped by nursing or medical staff when 
inside the high-risk area, or often, more effectively, by other patients. 
Routine medication for both adults and children included analgesia, 
antiemetics, antidiarrhoeal medication, antimalarial treat ment, and 
empiric antibiotics, all given orally.
Drs Rosie Burton and Tom Boyles are infectious diseases specialists 
in Cape Town, who worked with the Ebola outbreak in West Africa 
in late 2014. They were involved in different aspects of clinical care, 
and worked in different health facilities. The two give accounts of 
their experiences.
The experience of all those who have worked with Ebola during the current outbreak has been different, and varied by time and place. I 
worked with Médicins sans Frontières in Monrovia during October/November 2014. This was the first-ever outbreak of Ebola virus disease 
in the overcrowded and impoverished areas of a capital city; Ebola was spreading rapidly, and case management had to be upscaled on an 
unprecedented basis. It was also a time of many questions: for clinicians, these centred on how to optimise survival, and how to maximise 
care in a resource-limited environment.
S Afr Med J 2015;105(12):1006-1008. DOI:10.7196/SAMJ.2015.v105i12.10239
PHOTO ESSAY
Ebola: Experiences from the field – Liberia
R Burton, BSc, PhD, MBBS, MRCOG, FCP (SA), Cert ID Phys (SA)
Physician and Infectious Diseases Specialist, Khayelitsha District Hospital, Cape Town, South Africa, and Department of Medicine,  
University of Cape Town
Corresponding author: R Burton (rosie@polka.co.za)
FORUM
1007       December 2015, Vol. 105, No. 12
Ward rounds in an Ebola  
treatment centre
The two physician assistants on duty and I did medical rounds twice 
a day. We went into the high-risk area as early in the morning and as 
late in the afternoon as possible, to avoid spending time in personal 
protective equipment (PPE) during the hottest time of day. We could 
spend between 1 and 2 hours in the high-risk area, depending on the 
heat, and had up to 60 patients to see. We would be dripping with 
sweat inside the PPE before we left the dressing station.
We started with the sickest patients, who would still be inside the 
tents, and worked our way to those who were relatively well, so that if 
we ran out of time, we would have seen those who needed the most 
care. In the tents it was extremely hot. Many patients had extensive 
diarrhoea and vomiting; despite regular cleaning, this was a difficult 
environment for sick patients. Clinical review largely consisted of 
assessing symptoms and functional status. Physical examination was 
very limited. Many patients were confused, and health workers in 
PPE would have been a cause of further disorientation.
Many questions, few answers
The major question we had as doctors was how we could improve 
survival. Most of the time, clinical practice is evidence based; with 
Ebola, evidence for best management was minimal. It was therefore 
difficult to know if our clinical care was of benefit, simply futile, or 
could even cause harm.
Some patients were barely responsive and severely dehydrated 
when admitted, and died soon afterwards. Others appeared relatively 
well, mobilising and eating and drinking, and then died unexpectedly. 
Some survived against all odds, when death had seemed inevitable. 
As clinical doctors we met together most afternoons to discuss 
our problem patients and how we could improve management. 
Every day discussion soon focused on what we did not know, the 
pathophysiology that could explain our patients’ symptoms and 
clinical course, and how we could rapidly learn enough to make a 
difference.
A central issue was fluid and electrolyte depletion – how 
manage ment could be optimised, and whether aggressive fluid 
replace ment would improve outcomes. We were concerned 
that hypokalaemia contributed to mortality, and explained 
the unpredicted deaths. Many patients were tachypnoeic, not 
dyspnoeic, and were able to lie flat. We thought they were acidotic 
due to renal impairment, but had no means of verifying this. 
Thanks to excellent wi-fi, we read articles in the major journals 
as soon as they appeared, looking for data from elsewhere that 
would improve our management. Publications were appearing 
that argued that more intensive supportive care was both feasible 
in resource-poor environments, and would improve survival.[4,5] 
Diarrhoea of eight litres a day was reported; our fluid replace-
ment was nowhere near this volume.[6] Hypokalaemia and renal 
impairment were common findings.
Intravenous fluid administration was reinitiated when it was clear 
that the decline in cases was real and sustained. We began routinely 
supplementing all adults with oral postassium, and there were plans 
for point-of-care biochemical monitoring, including of potassium, 
which finally became possible in December.
There will never be an Ebola  
outbreak like this again
For me, the hardest part of working with Ebola was not the physical 
exhaustion of working in PPE in the heat, the emotional impact of 
patients dying from a rapidly fatal disease, or personal concerns 
about becoming infected. It was instead the lack of knowledge about 
Ebola, and not knowing if we could have done more to prevent 
people dying. Now, nine months on, so much more is known about 
Ebola. The necessity for optimising supportive care and biochemical 
testing is acknowledged. Ebola priorities and clinical care evolved 
throughout this ever-changing outbreak.[7,8] I was there during a 
particularly historic time, and what I experienced is part of the 
process of this evolution.
There will be undoubtedly be further outbreaks of Ebola; however, it 
should never be like this again. Never again will so much be unknown 
in terms of diagnosis, clinical management and optimising survival, and 
never again should the global response be so inadequate for so long.
Forty percent of people survived Ebola. The patients in the photographs had 
been discharged from the high-risk area and were going home.
A patient’s experience of Ebola
Only a father and his 5-year-old son were going home. His wife 
had died shortly after admission. Their 9-month-old baby was 
initially cared for by another patient, who was recovering well and 
had lost her own baby.
I have a strong memory of the baby, dressed beautifully, happy 
and smiling, sitting on a mattress outside with his temporary 
mum. He was so admired by staff and patients alike. It could have 
been any relaxed family gathering; it felt incongruous this was the 
high-risk area of an Ebola treatment centre. Despite appearing 
well, the baby continued to have a high fever that paracetamol 
could not resolve.
The father recovered. He took care of the baby again, who 
continued to smile, until one morning he died suddenly in his 
father’s arms.
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